| Primary |
| Rhinitis Allergic |
27.7% |
| Multiple Allergies |
9.2% |
| Vasomotor Rhinitis |
9.2% |
| Hypersensitivity |
7.7% |
| Nasal Congestion |
7.7% |
| Rhinitis |
6.2% |
| Ill-defined Disorder |
4.6% |
| Seasonal Allergy |
4.6% |
| Anticoagulant Therapy |
3.1% |
| Postnasal Drip |
3.1% |
| Upper Respiratory Tract Infection |
3.1% |
| Contraception |
1.5% |
| Cough |
1.5% |
| Ear Disorder |
1.5% |
| Eustachian Tube Dysfunction |
1.5% |
| Mucosal Inflammation |
1.5% |
| Muscle Spasticity |
1.5% |
| Nasal Disorder |
1.5% |
| Perennial Allergy |
1.5% |
| Sinus Disorder |
1.5% |
|
| Pregnancy |
11.8% |
| Anosmia |
8.8% |
| Muscle Spasms |
8.8% |
| Syncope |
8.8% |
| Vomiting |
8.8% |
| Grand Mal Convulsion |
5.9% |
| Malaise |
5.9% |
| Palpitations |
5.9% |
| Arrhythmia |
2.9% |
| Blood Glucose Increased |
2.9% |
| Blood Pressure Diastolic Decreased |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Heart Rate Increased |
2.9% |
| Hip Arthroplasty |
2.9% |
| Hypoaesthesia Facial |
2.9% |
| Hyposmia |
2.9% |
| Impaired Driving Ability |
2.9% |
| International Normalised Ratio Increased |
2.9% |
| Intra-uterine Death |
2.9% |
| Macular Degeneration |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
29.3% |
| Seasonal Allergy |
10.3% |
| Mycotic Allergy |
7.8% |
| Prophylaxis |
7.8% |
| Drug Use For Unknown Indication |
5.2% |
| Muscle Spasticity |
4.3% |
| Sleep Disorder |
4.3% |
| Plasma Cell Myeloma |
3.4% |
| Rhinitis |
3.4% |
| Adenoma Benign |
2.6% |
| Asthma |
2.6% |
| Glaucoma |
2.6% |
| Herniated Disc |
2.6% |
| Hypercholesterolaemia |
2.6% |
| Pain |
2.6% |
| Demyelinating Polyneuropathy |
1.7% |
| Hypersensitivity |
1.7% |
| Myocardial Infarction |
1.7% |
| Nasal Congestion |
1.7% |
| Rhinitis Allergic |
1.7% |
|
| Pain |
11.5% |
| Skin Discolouration |
11.5% |
| Weight Decreased |
7.7% |
| Weight Increased |
7.7% |
| Amnesia |
3.8% |
| Blood Pressure Increased |
3.8% |
| Drug Hypersensitivity |
3.8% |
| Drug Screen False Positive |
3.8% |
| Dysphonia |
3.8% |
| Hyponatraemia |
3.8% |
| Ill-defined Disorder |
3.8% |
| Menorrhagia |
3.8% |
| Pain In Jaw |
3.8% |
| Pharmaceutical Product Complaint |
3.8% |
| Productive Cough |
3.8% |
| Pruritus |
3.8% |
| Pulmonary Embolism |
3.8% |
| Rhinorrhoea |
3.8% |
| Thyroid Neoplasm |
3.8% |
| Trigeminal Neuralgia |
3.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.5% |
| Product Used For Unknown Indication |
19.3% |
| Asthma |
13.1% |
| Hypersensitivity |
6.6% |
| Hypertension |
4.6% |
| Pain |
3.6% |
| Depression |
3.0% |
| Rhinitis Allergic |
2.8% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Multiple Allergies |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Osteoporosis |
1.9% |
| Arthritis |
1.7% |
| Anxiety |
1.6% |
| Insomnia |
1.6% |
| Blood Cholesterol Increased |
1.3% |
| Restless Legs Syndrome |
1.2% |
| Contraception |
1.2% |
| Seasonal Allergy |
1.2% |
|
| Vomiting |
11.8% |
| Weight Decreased |
10.9% |
| Weight Increased |
10.5% |
| Nausea |
5.7% |
| Wheezing |
5.4% |
| Dyspnoea |
5.0% |
| Vision Blurred |
4.8% |
| Pain |
4.5% |
| Urticaria |
4.5% |
| Anaphylactic Reaction |
3.9% |
| Pruritus |
3.8% |
| Pulmonary Embolism |
3.8% |
| Convulsion |
3.6% |
| Urinary Tract Infection |
3.6% |
| Tremor |
3.4% |
| Product Quality Issue |
3.2% |
| Suicidal Ideation |
3.2% |
| Death |
2.9% |
| Deep Vein Thrombosis |
2.9% |
| Rash |
2.9% |
|
| Interacting |
| Hypersensitivity |
66.7% |
| Joint Injury |
33.3% |
|
|
